GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » FCF Yield %

Piramal Pharma (NSE:PPLPHARMA) FCF Yield % : 1.04 (As of May. 01, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Piramal Pharma's Trailing 12-Month Free Cash Flow is ₹2,925 Mil, and Market Cap is ₹278,675 Mil. Therefore, Piramal Pharma's FCF Yield % for today is 1.04%.

The historical rank and industry rank for Piramal Pharma's FCF Yield % or its related term are showing as below:

NSE:PPLPHARMA' s FCF Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.04
Current: 1.04


During the past 4 years, the highest FCF Yield % of Piramal Pharma was 1.04%. The lowest was 0.00%. And the median was 0.00%.

NSE:PPLPHARMA's FCF Yield % is ranked better than
57.41% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 0.01 vs NSE:PPLPHARMA: 1.04

Piramal Pharma's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.


Piramal Pharma FCF Yield % Historical Data

The historical data trend for Piramal Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma FCF Yield % Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
FCF Yield %
- - -5.91 1.72

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Piramal Pharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Piramal Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's FCF Yield % falls into.


;
;

Piramal Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Piramal Pharma's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=2925 / 169892.2624
=1.72%

Piramal Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 351562.09125
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Piramal Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Piramal Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Piramal Pharma Business Description

Traded in Other Exchanges
Address
Kamani Junction, LBS Marg, Ground Floor, Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kurla (West), Mumbai, MH, IND, 400070
Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.

Piramal Pharma Headlines

No Headlines